Mike Wenger joined CRIO as Chief Innovation Officer in 2025, bringing nearly two decades of experience building solutions that improve patient engagement, streamline clinical trial operations, and enhance site efficiency. As founder of VersaTrial (acquired by Florence Healthcare), co-creator of TrialScope Connect (now Citeline Connect), and a technology strategist at the Michael J. Fox Foundation, Mike has pioneered innovative solutions that remove friction from research. At CRIO, he’s harnessing AI to eliminate administrative burdens so site teams can focus on what matters most—their patients—while advancing CRIO’s mission to reimagine clinical trials.